In a case control study, 100 infertile PCOS women based on a randomly divided into two groups. Group I (n?=?50) were treated with metformin 1500?mg/day, and group II (n?=?50) treated with metformin 1500?mg/day plus Calcium 1000?mg/day and Vitamin D 100000?IU/month for 6 months. Patients were followed by transvaginal sonography at first, 3 and 6 months later for evaluating dominant follicle.
BMI, menstrual regularity, follicle diameter, pregnancy, serum 25-OH-vitamin D level were matured and compared in two groups.
BMI decreased almost significantly (25.49?¡À?1.88 vs 26.28?¡À?2.15, p: 0.054) in group II. A better improvement was gained in regulating menstrual abnormalities (70 % vs 58 % , p: 0.211), follicle maturation (28 % vs 22 % , p: 0.698), and infertility (18 % vs 12 % , p: 0.401) in group II compared with group I, but these results were not statistically significant. Eighty three percent of all the PCOS patients showed vitamin D deficiency while 35 % were severely deficient. The serum 25-OH-vitamin D mean levels were 13.38?¡À?6.48?ng/ml. Vitamin D deficiency was recompensed in 74 % of the PCOS patients who had taken calcium & vitamin D supplementation. There was no correlation between BMI and 25-OH-VD before and after the treatment (p?¡Ý?.01).
This study showed the positive effects of calcium & vitamin D supplementation on weight loss, follicle maturation, menstrual regularity, and improvement of hyperandrogenism, in infertile women with PCOS.